IL69269A - Microbial production of polypeptides corresponding to herpes simplex virus type 1-gd glycoproteins and type 2-gd glycoproteins - Google Patents

Microbial production of polypeptides corresponding to herpes simplex virus type 1-gd glycoproteins and type 2-gd glycoproteins

Info

Publication number
IL69269A
IL69269A IL69269A IL6926983A IL69269A IL 69269 A IL69269 A IL 69269A IL 69269 A IL69269 A IL 69269A IL 6926983 A IL6926983 A IL 6926983A IL 69269 A IL69269 A IL 69269A
Authority
IL
Israel
Prior art keywords
glycoproteins
type
herpes simplex
simplex virus
polypeptides corresponding
Prior art date
Application number
IL69269A
Other languages
English (en)
Other versions
IL69269A0 (en
Original Assignee
Molecular Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27410368&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL69269(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US06/400,028 external-priority patent/US4818694A/en
Priority claimed from US06/510,551 external-priority patent/US4891315A/en
Application filed by Molecular Genetics Inc filed Critical Molecular Genetics Inc
Publication of IL69269A0 publication Critical patent/IL69269A0/xx
Publication of IL69269A publication Critical patent/IL69269A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL69269A 1982-07-20 1983-07-18 Microbial production of polypeptides corresponding to herpes simplex virus type 1-gd glycoproteins and type 2-gd glycoproteins IL69269A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/400,028 US4818694A (en) 1982-07-20 1982-07-20 Production of herpes simplex viral protein
US43636882A 1982-10-25 1982-10-25
US06/510,551 US4891315A (en) 1982-10-25 1983-07-06 Production of herpes simplex viral porteins

Publications (2)

Publication Number Publication Date
IL69269A0 IL69269A0 (en) 1983-11-30
IL69269A true IL69269A (en) 1989-12-15

Family

ID=27410368

Family Applications (1)

Application Number Title Priority Date Filing Date
IL69269A IL69269A (en) 1982-07-20 1983-07-18 Microbial production of polypeptides corresponding to herpes simplex virus type 1-gd glycoproteins and type 2-gd glycoproteins

Country Status (14)

Country Link
EP (1) EP0101655B1 (xx)
CA (1) CA1295561C (xx)
DE (1) DE3382072D1 (xx)
DK (1) DK333183A (xx)
ES (2) ES524245A0 (xx)
FI (1) FI83974C (xx)
GR (1) GR78647B (xx)
IE (1) IE56902B1 (xx)
IL (1) IL69269A (xx)
NO (1) NO172855C (xx)
NZ (1) NZ204948A (xx)
PH (1) PH21239A (xx)
PL (1) PL150654B1 (xx)
PT (1) PT77014B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3228501A1 (de) * 1982-07-30 1984-02-02 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines herpes-antigens, dazu geeignetes mittel sowie verfahren zu seiner herstellung und die verwendung dieses antigens
DK305784A (da) * 1983-06-23 1984-12-24 Stanley Person Ikke-glycosyleret aminosyrekaede af glycoprotein b fra herpes virus type 1 og 2
NZ209308A (en) * 1983-08-30 1991-08-27 Genentech Inc Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein
NZ209307A (en) * 1983-08-30 1990-07-26 Genentech Inc Diagnostic product: antigenic peptide produced by recombinant dna techniques
US7264817B1 (en) 1983-08-30 2007-09-04 Genentech, Inc. Immunogenic composition based on a truncated derivative of a membrane bound protein and process for making it
JPS615786A (ja) * 1984-06-19 1986-01-11 Chemo Sero Therapeut Res Inst 単純ヘルペスウイルス遺伝子を組込んだ組換えｄｎａ、形質転換動物細胞および単純ヘルペスウイルス蛋白質の製法
DE3582200D1 (de) * 1984-07-20 1991-04-25 Chemo Sero Therapeut Res Inst Rekombinante dns, enthaltend ein herpes-simplex-virus-gen oder ein fragment davon, hefe transformiert mit dieser rekombinanten dns und verfahren zur herstellung von herpes-simplex-virus-proteinen.
US4659568A (en) * 1985-02-27 1987-04-21 American Cyanamid Company Process for solubilization, purification and characterization of protein from insoluble protein aggregates or complexes and compositions of matter therefrom
DE3510734A1 (de) * 1985-03-25 1986-09-25 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines fuer herpes simplex virus typ 2 spezifischen antigens, dazu geeignetes mittel und verwendung dieses antigens
JPH0668B2 (ja) * 1985-08-30 1994-01-05 財団法人化学及血清療法研究所 単純ヘルペスウイルス遺伝子が組込まれた組換えプラスミド
EP0471778A1 (en) * 1989-05-12 1992-02-26 Ciba Corning Diagnostics Corp. Herpes simplex virus type 2-glycoprotein g proteins and polypeptides
US5149532A (en) * 1989-11-01 1992-09-22 Cedars Sinai Medical Center Method of vaccine or toxoid preparation and immunization by colonization with recombinant microorganisms
JP2007505147A (ja) 2003-09-12 2007-03-08 アンティジェニクス インコーポレーテッド 単純ヘルペスウイルス感染の治療および予防用ワクチン
CN106456805B (zh) 2014-03-03 2020-01-10 阿尔伯特爱因斯坦医学院公司 重组单纯疱疹病毒2(hsv-2)疫苗载体
US10918712B2 (en) 2014-03-03 2021-02-16 Albert Einstein College Of Medicine Passive transfer of immunity using recombinant herpes simplex virus 2 (HSV-2) vaccine vectors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3228501A1 (de) * 1982-07-30 1984-02-02 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines herpes-antigens, dazu geeignetes mittel sowie verfahren zu seiner herstellung und die verwendung dieses antigens

Also Published As

Publication number Publication date
IL69269A0 (en) 1983-11-30
FI83974B (fi) 1991-06-14
NO172855B (no) 1993-06-07
FI83974C (fi) 1991-09-25
NO172855C (no) 1993-09-15
IE831690L (en) 1984-01-20
NZ204948A (en) 1987-10-30
GR78647B (xx) 1984-09-27
PL243134A1 (en) 1984-08-13
ES8504254A1 (es) 1985-04-01
ES8505253A1 (es) 1985-05-16
NO832626L (no) 1984-01-23
DK333183A (da) 1984-01-21
IE56902B1 (en) 1992-01-29
PL150654B1 (en) 1990-06-30
ES529225A0 (es) 1985-05-16
DE3382072D1 (de) 1991-02-07
DK333183D0 (da) 1983-07-19
PT77014B (en) 1986-01-24
CA1295561C (en) 1992-02-11
FI832632A0 (fi) 1983-07-19
PH21239A (en) 1987-08-21
EP0101655B1 (en) 1991-01-02
EP0101655A3 (en) 1985-12-18
EP0101655A2 (en) 1984-02-29
ES524245A0 (es) 1985-04-01
FI832632A (fi) 1984-01-21
PT77014A (en) 1983-08-01

Similar Documents

Publication Publication Date Title
AU574323B2 (en) Yeast expression of interferon and other proteins
AU582110B2 (en) Microboal production of human fibroblast interferon
IL72785A (en) Herpes simplex virus vaccines based on glycoproteins and process for making them
EP0113319A3 (en) Cell lines and their use for the production of proteins
IL69269A (en) Microbial production of polypeptides corresponding to herpes simplex virus type 1-gd glycoproteins and type 2-gd glycoproteins
EP0161892A3 (en) Forming of stiffened panels
DE3170887D1 (en) Improvements in and relating to gasket manufacture
ZA835138B (en) Production of herpes simplex viral proteins
AU561169B2 (en) Improvements in or relating to means of transportation
DE3378469D1 (en) Diaminopyrimidines and their production
GB2121053B (en) Production of interleukin and its analogous immune regulating factors
AU1678783A (en) Production of herpes simplex viral proteins
DE3378383D1 (en) Improvements in and relating to autoteller systems
IL69094A0 (en) Ointment and its preparation
DE3276871D1 (en) Preparation of 6-deoxy-d-fructose and 6-deoxy-l-sorbose
GB2079273B (en) Preparation of 1-hydropentadecafluoro-adamantane and perfluoroadamantane
GB2106222B (en) Improvements in and relating to practice ammunition
AU560143B2 (en) Improvements in and relating to wingsail craft and wingsails therefore
JPS55101371A (en) Wearing plate and system of wearing plate
DE3372813D1 (en) Lamp framework and its suspension
ZA81956B (en) Improvement in and relating to the jolning of tubes
GB2118992B (en) Securing panels to surfaces
AU3127384A (en) Isolation and purification of interferon
GB8314853D0 (en) Production and immobillisation of modified proteins
IE820313L (en) Expression of polypeptides in yeast

Legal Events

Date Code Title Description
KB Patent renewed
KB20 Patent renewed for 20 years
EXP Patent expired